Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells

Chimeric Antigen Receptor T-Cell Therapy, From Approval to Practice, Managing Side EffectsПодробнее

Saudi Lymphoma/Myeloma & Hematopathology Overview 2024 (OCt 25-26, 2024) Le Meridien Medina HotelПодробнее

Overview of Chimeric Antigen Receptor (CAR) T cells | Dr Ramavath DevПодробнее

Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with NHL and CLLПодробнее

CAR-T Revolution – Advancing Lymphoma Treatment with Precision & InnovationПодробнее

Car T-Cell Therapy for Lymphoma | LyfboatПодробнее

Dan's Story: CAR T-Cell Therapy Treatment for LymphomaПодробнее

Update on CAR T-Cell Therapy | Lymphoma Research Foundation WebinarsПодробнее

Understanding the Mechanisms of Resistance in CAR T Immunotherapy for Lymphoma and Strategies to...Подробнее

Oncology Today with Dr Neil Love: Peripheral T-Cell LymphomaПодробнее

CAR-T Therapy in India: Revolutionizing Chimeric Antigen Receptor Cancer CareПодробнее

CAR T-Cell Therapy in Lymphoma: Preparation, Communication, and AftercareПодробнее

What’s New In Mantle Cell Lymphoma: Updates from ASCO 2024 & the EHA Hybrid CongressПодробнее

CAR T-Cell Therapy in Non-Hodgkin Lymphoma and Multiple Myeloma: A Clinical UpdateПодробнее

Optimizing outcomes before and after CAR T-cell therapy in patients with large B-cell lymphomaПодробнее

CAR T Cells in B-Cell Lymphoma: Implications of New Data and New TherapyПодробнее

An overview of CAR T-cell therapies in the treatment of patients with MCLПодробнее

Hot Topics In Non-Hodgkin Lymphoma: Updates from ASCO 2024 & the EHA Hybrid CongressПодробнее

CAR T-Cell treatment for Lymphoma & other Cancer, with Mark Hamilton, M.D., Ph.D.Подробнее

Risk of Second Tumors and T-Cell Lymphoma after CAR-T Cell TherapyПодробнее